Skip to main content
Erschienen in: Journal of Clinical Immunology 5/2008

01.09.2008

Histamine Release and Inflammatory Cell Infiltration in Airway Mucosa in Methylene Diphenyl Diisocyanate (MDI)-Induced Occupational Asthma

verfasst von: Gyu-Young Hur, Seung-Soo Sheen, Young-Mi Kang, Dong-Hee Koh, Han-Jung Park, Young-Min Ye, Hyun-ee Yim, Kyoo-Sang Kim, Hae-Sim Park

Erschienen in: Journal of Clinical Immunology | Ausgabe 5/2008

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Although methylene diphenyl diisocyanate (MDI) is widely used in industries, there have been few studies of the pathogenic mechanisms of MDI-induced occupational asthma (MDI-OA).

Methods

We performed immunohistochemical analyses, measured inflammatory mediators and cytokines, and quantified histamine release (HR) from peripheral basophils in MDI-OA patients. Thirteen MDI-exposed workers (five MDI-OA, two MDI-induced esoinophilic bronchitis, and six asymptomatic exposed controls, AEC) were enrolled.

Results and Discussion

Immunochemical analyses indicated significantly increased anti-eosinophilic cationic protein-stained cells in MDI-OA patients as compared with controls (P < 0.05). Sputum eosinophil cationic protein levels were increased after MDI-specific inhalation challenge test in MDI-OA/EB patients (P < 0.02). Sputum eosinophil counts were highly correlated with IL-8 and MMP-9 levels (P < 0.05 and P < 0.01, respectively). Basophil HR was significantly increased in MDI-OA patients after stimulations with anti-IgG4 and MDI–human serum albumin conjugates (both P < 0.05). Eosinophil activation is a major feature of airway inflammation in MDI-OA patients. Increased HR by MDI may contribute to the pathogenic mechanisms of MDI-OA.
Literatur
1.
Zurück zum Zitat Mapp CE. Agents, old and new, causing occupational asthma. Occup Environ Med. 2001;58:290, 354–60.CrossRef Mapp CE. Agents, old and new, causing occupational asthma. Occup Environ Med. 2001;58:290, 354–60.CrossRef
2.
Zurück zum Zitat Mapp CE, Boschetto P, Maestrelli P, Fabbri LM. Occupational asthma. Am J Respir Crit Care Med. 2005;172:280–305.PubMedCrossRef Mapp CE, Boschetto P, Maestrelli P, Fabbri LM. Occupational asthma. Am J Respir Crit Care Med. 2005;172:280–305.PubMedCrossRef
3.
Zurück zum Zitat Baur X, Seemann U, Marczynski B, Chen Z, Raulf-Heimsoth M. Humoral and cellular immune responses in asthmatic isocyanate workers: report of two cases. Am J Ind Med. 1996;29:467–73.PubMedCrossRef Baur X, Seemann U, Marczynski B, Chen Z, Raulf-Heimsoth M. Humoral and cellular immune responses in asthmatic isocyanate workers: report of two cases. Am J Ind Med. 1996;29:467–73.PubMedCrossRef
4.
Zurück zum Zitat Keskinen H, Tupasela O, Tiikkainen U, Nordman H. Experiences of specific IgE in asthma due to diisocyanates. Clin Allergy. 1988;18:597–604.PubMedCrossRef Keskinen H, Tupasela O, Tiikkainen U, Nordman H. Experiences of specific IgE in asthma due to diisocyanates. Clin Allergy. 1988;18:597–604.PubMedCrossRef
5.
Zurück zum Zitat Liss GM, Bernstein DI, Moller DR, Gallagher JS, Stephenson RL, Bernstein IL. Pulmonary and immunologic evaluation of foundry workers exposed to methylene diphenyldiisocyanate (MDI). J Allergy Clin Immunol. 1988;82:55–61.PubMedCrossRef Liss GM, Bernstein DI, Moller DR, Gallagher JS, Stephenson RL, Bernstein IL. Pulmonary and immunologic evaluation of foundry workers exposed to methylene diphenyldiisocyanate (MDI). J Allergy Clin Immunol. 1988;82:55–61.PubMedCrossRef
6.
Zurück zum Zitat Tee RD, Cullinan P, Welch J, Burge PS, Newman-Taylor AJ. Specific IgE to isocyanates: a useful diagnostic role in occupational asthma. J Allergy Clin Immunol. 1998;101:709–15.PubMedCrossRef Tee RD, Cullinan P, Welch J, Burge PS, Newman-Taylor AJ. Specific IgE to isocyanates: a useful diagnostic role in occupational asthma. J Allergy Clin Immunol. 1998;101:709–15.PubMedCrossRef
7.
Zurück zum Zitat Hur GY, Koh DH, Choi GS, Park HJ, Choi SJ, Ye YM et al. Clinical and immunologic findings of methylene diphenyl diisocyanate induced occupational asthma in a car upholstery factory. Clin Exp Allergy. 2008; in press. Hur GY, Koh DH, Choi GS, Park HJ, Choi SJ, Ye YM et al. Clinical and immunologic findings of methylene diphenyl diisocyanate induced occupational asthma in a car upholstery factory. Clin Exp Allergy. 2008; in press.
8.
Zurück zum Zitat Lee YM, Kim HA, Park HS, Lee SK, Nahm DH. Exposure to toluene diisocyanate (TDI) induces IL-8 production from bronchial epithelial cells: effect of pro-inflammatory cytokines. J Korean Med Sci. 2003;18:809–12.PubMed Lee YM, Kim HA, Park HS, Lee SK, Nahm DH. Exposure to toluene diisocyanate (TDI) induces IL-8 production from bronchial epithelial cells: effect of pro-inflammatory cytokines. J Korean Med Sci. 2003;18:809–12.PubMed
9.
Zurück zum Zitat Park H, Jung K, Kim H, Nahm D, Kang K. Neutrophil activation following TDI bronchial challenges to the airway secretion from subjects with TDI-induced asthma. Clin Exp Allergy. 1999;29:1395–401.PubMedCrossRef Park H, Jung K, Kim H, Nahm D, Kang K. Neutrophil activation following TDI bronchial challenges to the airway secretion from subjects with TDI-induced asthma. Clin Exp Allergy. 1999;29:1395–401.PubMedCrossRef
10.
Zurück zum Zitat Hur GY, Koh DH, Choi GS, Park HJ, Choi SJ, Ye YM, et al. Clinical and immunologic findings of methylene diphenyl diisocyanate induced occupational asthma in a car upholstery factory. Clin Exp Allergy 2008;38:586–93.PubMedCrossRef Hur GY, Koh DH, Choi GS, Park HJ, Choi SJ, Ye YM, et al. Clinical and immunologic findings of methylene diphenyl diisocyanate induced occupational asthma in a car upholstery factory. Clin Exp Allergy 2008;38:586–93.PubMedCrossRef
11.
Zurück zum Zitat Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 2000;161:309–29.PubMed Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 2000;161:309–29.PubMed
12.
Zurück zum Zitat Zammit-Tabona M, Sherkin M, Kijek K, Chan H, Chan-Yeung M. Asthma caused by diphenylmethane diisocyanate in foundry workers. Clinical, bronchial provocation, and immunologic studies. Am Rev Respir Dis. 1983;128:226–30.PubMed Zammit-Tabona M, Sherkin M, Kijek K, Chan H, Chan-Yeung M. Asthma caused by diphenylmethane diisocyanate in foundry workers. Clinical, bronchial provocation, and immunologic studies. Am Rev Respir Dis. 1983;128:226–30.PubMed
13.
Zurück zum Zitat Jang AS, Choi IS, Park CS. Immunohistochemically stained activated eosinophils in sputum in patients with asthma. Respiration. 2000;67:183–8.PubMedCrossRef Jang AS, Choi IS, Park CS. Immunohistochemically stained activated eosinophils in sputum in patients with asthma. Respiration. 2000;67:183–8.PubMedCrossRef
14.
Zurück zum Zitat Bae JS, Kim SH, Ye YM, Yoon HJ, Suh CH, Nahm DH, et al. Significant association of FcepsilonRIalpha promoter polymorphisms with aspirin-intolerant chronic urticaria. J Allergy Clin Immunol. 2007;119:449–56.PubMedCrossRef Bae JS, Kim SH, Ye YM, Yoon HJ, Suh CH, Nahm DH, et al. Significant association of FcepsilonRIalpha promoter polymorphisms with aspirin-intolerant chronic urticaria. J Allergy Clin Immunol. 2007;119:449–56.PubMedCrossRef
15.
Zurück zum Zitat Vasagar K, Vonakis BM, Gober LM, Viksman A, Gibbons SP Jr, Saini SS. Evidence of in vivo basophil activation in chronic idiopathic urticaria. Clin Exp Allergy. 2006;36:770–6.PubMedCrossRef Vasagar K, Vonakis BM, Gober LM, Viksman A, Gibbons SP Jr, Saini SS. Evidence of in vivo basophil activation in chronic idiopathic urticaria. Clin Exp Allergy. 2006;36:770–6.PubMedCrossRef
16.
Zurück zum Zitat Tong LJ, Balakrishnan G, Kochan JP, Kinet JP, Kaplan AP. Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol. 1997;99:461–5.PubMedCrossRef Tong LJ, Balakrishnan G, Kochan JP, Kinet JP, Kaplan AP. Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol. 1997;99:461–5.PubMedCrossRef
17.
Zurück zum Zitat Jarjour NN, Sedgwick JB, Swensen CA, Busse WW. Late allergic airway response to segmental bronchopulmonary provocation in allergic subjects is related to peripheral blood basophil histamine release. J Allergy Clin Immunol. 1997;99:87–93.PubMed Jarjour NN, Sedgwick JB, Swensen CA, Busse WW. Late allergic airway response to segmental bronchopulmonary provocation in allergic subjects is related to peripheral blood basophil histamine release. J Allergy Clin Immunol. 1997;99:87–93.PubMed
18.
Zurück zum Zitat Saetta M, Di Stefano A, Maestrelli P, De Marzo N, Milani GF, Pivirotto F, et al. Airway mucosal inflammation in occupational asthma induced by toluene diisocyanate. Am Rev Respir Dis. 1992;145:160–8.PubMed Saetta M, Di Stefano A, Maestrelli P, De Marzo N, Milani GF, Pivirotto F, et al. Airway mucosal inflammation in occupational asthma induced by toluene diisocyanate. Am Rev Respir Dis. 1992;145:160–8.PubMed
19.
Zurück zum Zitat Di Stefano A, Saetta M, Maestrelli P, Milani G, Pivirotto F, Mapp CE, et al. Mast cells in the airway mucosa and rapid development of occupational asthma induced by toluene diisocyanate. Am Rev Respir Dis. 1993;147:1005–9.PubMed Di Stefano A, Saetta M, Maestrelli P, Milani G, Pivirotto F, Mapp CE, et al. Mast cells in the airway mucosa and rapid development of occupational asthma induced by toluene diisocyanate. Am Rev Respir Dis. 1993;147:1005–9.PubMed
20.
Zurück zum Zitat Park HS, Hwang SC, Nahm DH, Yim HE. Immunohistochemical characterization of the cellular infiltrate in airway mucosa of toluene diisocyanate (TDI)-induced asthma: comparison with allergic asthma. J Korean Med Sci. 1998;13:21–6.PubMed Park HS, Hwang SC, Nahm DH, Yim HE. Immunohistochemical characterization of the cellular infiltrate in airway mucosa of toluene diisocyanate (TDI)-induced asthma: comparison with allergic asthma. J Korean Med Sci. 1998;13:21–6.PubMed
21.
Zurück zum Zitat Sun LZ, Elsayed S, Bronstad AM, Van Do T, Irgens A, Aardal NP, et al. Airway inflammation and bronchial remodelling in toluene diisocyanate-exposed BALB/c mouse model. Scand J Immunol. 2007;65:118–25.PubMedCrossRef Sun LZ, Elsayed S, Bronstad AM, Van Do T, Irgens A, Aardal NP, et al. Airway inflammation and bronchial remodelling in toluene diisocyanate-exposed BALB/c mouse model. Scand J Immunol. 2007;65:118–25.PubMedCrossRef
22.
Zurück zum Zitat Mapp CE, Lapa e Silva JR, Lucchini RE, Chitano P, Rado V, Saetta M, et al. Inflammatory events in the blood and airways of guinea pigs immunized to toluene diisocyanate. Am J Respir Crit Care Med. 1996;154:201–8.PubMed Mapp CE, Lapa e Silva JR, Lucchini RE, Chitano P, Rado V, Saetta M, et al. Inflammatory events in the blood and airways of guinea pigs immunized to toluene diisocyanate. Am J Respir Crit Care Med. 1996;154:201–8.PubMed
23.
Zurück zum Zitat Bentley AM, Maestrelli P, Saetta M, Fabbri LM, Robinson DS, Bradley BL, et al. Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma. J Allergy Clin Immunol. 1992;89:821–9.PubMedCrossRef Bentley AM, Maestrelli P, Saetta M, Fabbri LM, Robinson DS, Bradley BL, et al. Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma. J Allergy Clin Immunol. 1992;89:821–9.PubMedCrossRef
24.
Zurück zum Zitat Shakoory B, Fitzgerald SM, Lee SA, Chi DS, Krishnaswamy G. The role of human mast cell-derived cytokines in eosinophil biology. J Interferon Cytokine Res. 2004;24:271–81.PubMedCrossRef Shakoory B, Fitzgerald SM, Lee SA, Chi DS, Krishnaswamy G. The role of human mast cell-derived cytokines in eosinophil biology. J Interferon Cytokine Res. 2004;24:271–81.PubMedCrossRef
25.
Zurück zum Zitat Matheson JM, Johnson VJ, Luster MI. Immune mediators in a murine model for occupational asthma: studies with toluene diisocyanate. Toxicol Sci. 2005;84:99–109.PubMedCrossRef Matheson JM, Johnson VJ, Luster MI. Immune mediators in a murine model for occupational asthma: studies with toluene diisocyanate. Toxicol Sci. 2005;84:99–109.PubMedCrossRef
26.
Zurück zum Zitat Maestrelli P, Occari P, Turato G, Papiris SA, Di Stefano A, Mapp CE, et al. Expression of interleukin (IL)-4 and IL-5 proteins in asthma induced by toluene diisocyanate (TDI). Clin Exp Allergy. 1997;27:1292–8.PubMedCrossRef Maestrelli P, Occari P, Turato G, Papiris SA, Di Stefano A, Mapp CE, et al. Expression of interleukin (IL)-4 and IL-5 proteins in asthma induced by toluene diisocyanate (TDI). Clin Exp Allergy. 1997;27:1292–8.PubMedCrossRef
27.
Zurück zum Zitat Yuo A, Kitagawa S, Kasahara T, Matsushima K, Saito M, Takaku F. Stimulation and priming of human neutrophils by interleukin-8: cooperation with tumor necrosis factor and colony-stimulating factors. Blood. 1991;78:2708–14.PubMed Yuo A, Kitagawa S, Kasahara T, Matsushima K, Saito M, Takaku F. Stimulation and priming of human neutrophils by interleukin-8: cooperation with tumor necrosis factor and colony-stimulating factors. Blood. 1991;78:2708–14.PubMed
28.
Zurück zum Zitat Shute J. Interleukin-8 is a potent eosinophil chemo-attractant. Clin Exp Allergy. 1994;24:203–6.PubMedCrossRef Shute J. Interleukin-8 is a potent eosinophil chemo-attractant. Clin Exp Allergy. 1994;24:203–6.PubMedCrossRef
29.
Zurück zum Zitat Atkinson JJ, Senior RM. Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol. 2003;28:12–24.PubMedCrossRef Atkinson JJ, Senior RM. Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol. 2003;28:12–24.PubMedCrossRef
30.
Zurück zum Zitat Chiappara G, Gagliardo R, Siena A, Bonsignore MR, Bousquet J, Bonsignore G, et al. Airway remodelling in the pathogenesis of asthma. Curr Opin Allergy Clin Immunol. 2001;1:85–93.PubMed Chiappara G, Gagliardo R, Siena A, Bonsignore MR, Bousquet J, Bonsignore G, et al. Airway remodelling in the pathogenesis of asthma. Curr Opin Allergy Clin Immunol. 2001;1:85–93.PubMed
31.
Zurück zum Zitat Stahle-Backdahl M, Parks WC. 92-Kd gelatinase is actively expressed by eosinophils and stored by neutrophils in squamous cell carcinoma. Am J Pathol. 1993;142:995–1000.PubMed Stahle-Backdahl M, Parks WC. 92-Kd gelatinase is actively expressed by eosinophils and stored by neutrophils in squamous cell carcinoma. Am J Pathol. 1993;142:995–1000.PubMed
32.
Zurück zum Zitat Cataldo DD, Bettiol J, Noel A, Bartsch P, Foidart JM, Louis R. Matrix metalloproteinase-9, but not tissue inhibitor of matrix metalloproteinase-1, increases in the sputum from allergic asthmatic patients after allergen challenge. Chest. 2002;122:1553–9.PubMedCrossRef Cataldo DD, Bettiol J, Noel A, Bartsch P, Foidart JM, Louis R. Matrix metalloproteinase-9, but not tissue inhibitor of matrix metalloproteinase-1, increases in the sputum from allergic asthmatic patients after allergen challenge. Chest. 2002;122:1553–9.PubMedCrossRef
33.
Zurück zum Zitat Schwingshackl A, Duszyk M, Brown N, Moqbel R. Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF-alpha. J Allergy Clin Immunol. 1999;104:983–9.PubMedCrossRef Schwingshackl A, Duszyk M, Brown N, Moqbel R. Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF-alpha. J Allergy Clin Immunol. 1999;104:983–9.PubMedCrossRef
34.
Zurück zum Zitat Park HS, Kim HA, Jung JW, Kim YK, Lee SK, Kim SS, et al. Metalloproteinase-9 is increased after toluene diisocyanate exposure in the induced sputum from patients with toluene diisocyanate-induced asthma. Clin Exp Allergy. 2003;33:113–8.PubMedCrossRef Park HS, Kim HA, Jung JW, Kim YK, Lee SK, Kim SS, et al. Metalloproteinase-9 is increased after toluene diisocyanate exposure in the induced sputum from patients with toluene diisocyanate-induced asthma. Clin Exp Allergy. 2003;33:113–8.PubMedCrossRef
35.
Zurück zum Zitat Puxeddu I, Ribatti D, Crivellato E, Levi-Schaffer F. Mast cells and eosinophils: a novel link between inflammation and angiogenesis in allergic diseases. J Allergy Clin Immunol. 2005;116:531–6.PubMedCrossRef Puxeddu I, Ribatti D, Crivellato E, Levi-Schaffer F. Mast cells and eosinophils: a novel link between inflammation and angiogenesis in allergic diseases. J Allergy Clin Immunol. 2005;116:531–6.PubMedCrossRef
36.
Zurück zum Zitat Lee CG, Link H, Baluk P, Homer RJ, Chapoval S, Bhandari V, et al. Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med. 2004;10:1095–103.PubMedCrossRef Lee CG, Link H, Baluk P, Homer RJ, Chapoval S, Bhandari V, et al. Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med. 2004;10:1095–103.PubMedCrossRef
37.
Zurück zum Zitat Asai K, Kanazawa H, Kamoi H, Shiraishi S, Hirata K, Yoshikawa J. Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients. Clin Exp Allergy. 2003;33:595–9.PubMedCrossRef Asai K, Kanazawa H, Kamoi H, Shiraishi S, Hirata K, Yoshikawa J. Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients. Clin Exp Allergy. 2003;33:595–9.PubMedCrossRef
38.
Zurück zum Zitat Choi JH, Suh YJ, Lee SK, Suh CH, Nahm DH, Park HS. Acute and chronic changes of vascular endothelial growth factor (VEGF) in induced sputum of toluene diisocyanate (TDI)-induced asthma patients. J Korean Med Sci. 2004;19:359–63.PubMedCrossRef Choi JH, Suh YJ, Lee SK, Suh CH, Nahm DH, Park HS. Acute and chronic changes of vascular endothelial growth factor (VEGF) in induced sputum of toluene diisocyanate (TDI)-induced asthma patients. J Korean Med Sci. 2004;19:359–63.PubMedCrossRef
39.
Zurück zum Zitat Lummus ZL, Alam R, Bernstein JA, Bernstein DI. Characterization of histamine releasing factors in diisocyanate-induced occupational asthma. Toxicology. 1996;111:191–206.PubMedCrossRef Lummus ZL, Alam R, Bernstein JA, Bernstein DI. Characterization of histamine releasing factors in diisocyanate-induced occupational asthma. Toxicology. 1996;111:191–206.PubMedCrossRef
40.
Zurück zum Zitat Kivity S, Veintrov V, Fireman E, Agami O, Lerman Y. The in vivo effect of isocyanate-induced asthma on basophil histamine release. Allergy. 1998;53:407–10.PubMedCrossRef Kivity S, Veintrov V, Fireman E, Agami O, Lerman Y. The in vivo effect of isocyanate-induced asthma on basophil histamine release. Allergy. 1998;53:407–10.PubMedCrossRef
Metadaten
Titel
Histamine Release and Inflammatory Cell Infiltration in Airway Mucosa in Methylene Diphenyl Diisocyanate (MDI)-Induced Occupational Asthma
verfasst von
Gyu-Young Hur
Seung-Soo Sheen
Young-Mi Kang
Dong-Hee Koh
Han-Jung Park
Young-Min Ye
Hyun-ee Yim
Kyoo-Sang Kim
Hae-Sim Park
Publikationsdatum
01.09.2008
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 5/2008
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-008-9199-y

Weitere Artikel der Ausgabe 5/2008

Journal of Clinical Immunology 5/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.